Hello! I’m Noah Padilla and I just started my senior year at Ramon C Cortines School of Visual and Performing Arts in Los Angeles. The DREAM-High program has been a fascinating experience and extremely beneficial as furthering my knowledge of coding and technology has been something of importance to me. Seeing the usage of computational work to benefit society, in this case breast cancer research/patients, is a prime example of the ways we can use new technology to help and I am grateful to be a part of it.
Through hands-on programming, DREAM-High Scholars visualize and analyze genomics, clinical, and physical data from breast cancer cells. DREAM-High is a partnership between the Columbia Center for Cancer Systems Therapeutics, the Palazzo Strozzi Foundation USA, the Stanford Center for Cancer Systems Biology, and the Institute for Systems Biology.
In the DREAM-High program, Scholars learn to program in R, a language for statistical computing and graphics. They manipulate and write code in a cloud-based RStudio environment to analyze a wide range of data on breast cancer patients and cancer cell lines.
I created heat maps as colorized representations of data matrices. I reordered features and observations so that similar entities are close to each other in the graph. Heat maps make it easy to visualize and understand complex data.
I loaded and examined a data frame of clinical information from 1,082 breast cancer patients from The Cancer Genome Atlas (TCGA). I summarized clinical measurements on both the patients, such as gender and age, and the patients’ tumors, such as estrogen receptor status and histology.
I performed an integrative analysis of clinical measurements and gene expression data for 1,082 patients in the TCGA Breast Cancer cohort. By calculating heat maps and annotating them with clinical information, I detected patterns in the patients' expression profiles across 18,351 genes that correspond to luminal and triple negative breast cancers.
I discovered biological processes that distinguish cancer cell lines based on the aggressiveness of the cancers they model. For both breast cancer and colon cancer cell lines, I calculated, visualized, and functionally annotated differential gene expression profiles with data from the Physical Sciences in Oncology Cell Line Characterization Study.
I built linear regression models that are predictive of breast cancer survival from the METABRIC breast cancer dataset. I found that gene expression profiles of certain cancer genes are predictive of prognosis. Inclusion of additional features in my model increased its explanatory power.